![Bengt Erlandsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bengt Erlandsson
Corporate Officer/Principal chez
CINCLUS PHARMA HOLDING AB
Profil
Bengt Erlandsson is currently working as the Head-CMC & IP at Cinclus Pharma Holding AB. He has a graduate and doctorate degree from the Royal Institute of Technology.
Postes actifs de Bengt Erlandsson
| Sociétés | Poste | Début |
|---|---|---|
| CINCLUS PHARMA HOLDING AB | Corporate Officer/Principal | 01/01/2024 |
Formation de Bengt Erlandsson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Operates as a holding company through its subsidiaries develops small molecules for treatment of gastric acid related diseases | Health Technology |
